Literature DB >> 14468017

The histotoxic clostridial infections of man.

J D MACLENNAN.   

Abstract

Entities:  

Keywords:  GAS GANGRENE

Mesh：

Year:  1962        PMID： 14468017      PMCID： PMC441149     

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN： 0005-3678


× No keyword cloud information.
  297 in total

1.  [Non-pathogenic Clostridium sordellii, easily identified and frequently encountered variety].

Authors:  M HUET
Journal:  Arch Inst Pasteur Tunis       Date:  1961-06

2.  Unusual gas-forming infections.

Authors:  O W DOYLE
Journal:  Radiology       Date:  1959-01       Impact factor: 11.105

3.  Purification of hyaluronidase from Clostridium perfringens.

Authors:  E M BAKER; M E WEBSTER; M E FREEMAN; S G CARY; A C SANDERS
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

4.  Host resistance to bacteria and to bacterial toxins in traumatic shock.

Authors:  J FINE
Journal:  Ann Surg       Date:  1955-09       Impact factor: 12.969

5.  The separation of alpha toxin (lecithinase) from filtrates of Clostridium welchii.

Authors:  F B ROTH; L PILLEMER
Journal:  J Immunol       Date:  1953-06       Impact factor: 5.422

6.  THE TOXIC FACTORS IN EXPERIMENTAL TRAUMATIC SHOCK. V. CHEMICAL AND ENZYMATIC PROPERTIES OF MUSCLE EXUDATE.

Authors:  P C Zamecnik; J C Aub; A M Brues; S S Kety; I T Nathanson; A L Nutt; A Pope
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

7.  PHYSIOLOGIC ACTION OF CLOSTRIDIUM WELCHII (TYPE A) TOXINS IN DOGS.

Authors:  P C Zamecnik; I T Nathanson; J C Aub
Journal:  J Clin Invest       Date:  1947-05       Impact factor: 14.808

8.  Identification of the toxin of clostridium organisms in experimental intestinal obstruction.

Authors:  R E ANDERSON; C A TANTURI
Journal:  Arch Surg       Date:  1950-01

9.  Present role of zinc peroxide in treatment of surgical infections.

Authors:  F L MELENEY
Journal:  J Am Med Assoc       Date:  1952-08-16

10.  Proteolytic enzymes of Clostridium welchii.

Authors:  E BIDWELL
Journal:  Biochem J       Date:  1950-05       Impact factor: 3.857
View more
  78 in total

1.  SEROLOGY OF THE SOLUBLE ANTIGENS OF THE PATHOGENIC CLOSTRIDIA.

Authors:  P D ELLNER; S S GREEN
Journal:  J Bacteriol       Date:  1963-11       Impact factor: 3.490

2.  INHIBITION OF TOXIN PRODUCTION IN CLOSTRIDIUM PERFRINGENS IN VITRO BY HYPERBARIC OXYGEN.

Authors: 
Journal:  Antonie Van Leeuwenhoek       Date:  1965       Impact factor: 2.271

3.  An unusual case of pneumocephalus.

Authors:  P Bhogal; G Bhatnagar; J Manieson; T Booth; C Prendergast
Journal:  BMJ Case Rep       Date:  2011-11-01

4.  Fatal Clostridium septicum infection in a patient with a hematological malignancy.

Authors:  Ragesh Panikkath; Venu Konala; Deepa Panikkath; Elvira Umyarova; Fred Hardwicke
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-04

5.  Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes.

Authors:  N S DeSilva; P A Quinn
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

6.  Extracellular proteins in five clostridial species from human infections.

Authors:  C E Nord; T Wadström; K Dornbusch; B Wretlind
Journal:  Med Microbiol Immunol       Date:  1975-07-02       Impact factor: 3.402

7.  Regulation of protease production in Clostridium sporogenes.

Authors:  C Allison; G T Macfarlane
Journal:  Appl Environ Microbiol       Date:  1990-11       Impact factor: 4.792

8.  The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

Review 9.  Microbiology and management of myositis.

Authors:  Itzhak Brook
Journal:  Int Orthop       Date:  2004-08-26       Impact factor: 3.075

10.  Hyperbaric oxygen exposures at 3 and 4 atmospheres absolute pressure for experimental gas gangrene: succinate protection against oxygen toxicity.

Authors:  G B Hill
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.